Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 12
2006 15
2007 8
2008 11
2009 6
2010 5
2011 5
2012 11
2013 12
2014 17
2015 8
2016 5
2017 7
2018 4
2019 14
2020 28
2021 34
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Sezer A, Kilickap S, Gümüş M, Bondarenko I, Özgüroğlu M, Gogishvili M, Turk HM, Cicin I, Bentsion D, Gladkov O, Clingan P, Sriuranpong V, Rizvi N, Gao B, Li S, Lee S, McGuire K, Chen CI, Makharadze T, Paydas S, Nechaeva M, Seebach F, Weinreich DM, Yancopoulos GD, Gullo G, Lowy I, Rietschel P. Sezer A, et al. Among authors: kilickap s. Lancet. 2021 Feb 13;397(10274):592-604. doi: 10.1016/S0140-6736(21)00228-2. Lancet. 2021. PMID: 33581821 Clinical Trial.
Endpoints in oncology clinical trials.
Kilickap S, Demirci U, Karadurmus N, Dogan M, Akinci B, Sendur MAN. Kilickap S, et al. J BUON. 2018 Dec;23(7):1-6. J BUON. 2018. PMID: 30722104 Free article. Review.
Thirty-day mortality rates after immunotherapy initiation.
Sütcüoğlu O, İlhan A, Tacar SY, Güven DC, Uçar G, Karadurmuş N, Yıldız F, Eraslan E, Uncu D, Tural D, Üner A, Günel N, Özdemir N, Kılıçkap S, Öksüzoğlu ÖB, Özet A, Yazıcı O. Sütcüoğlu O, et al. Among authors: kilickap s. Immunotherapy. 2021 Dec;13(17):1419-1426. doi: 10.2217/imt-2021-0082. Epub 2021 Oct 22. Immunotherapy. 2021. PMID: 34676791
COVID-19 pandemic: changes in cancer admissions.
Guven DC, Aktas BY, Aksun MS, Ucgul E, Sahin TK, Yildirim HC, Guner G, Kertmen N, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Turker A, Uckun FM, Arik Z. Guven DC, et al. Among authors: kilickap s. BMJ Support Palliat Care. 2020 Jul 14:bmjspcare-2020-002468. doi: 10.1136/bmjspcare-2020-002468. Online ahead of print. BMJ Support Palliat Care. 2020. PMID: 32665259
P95 HER2 fragments and breast cancer outcome.
Tural D, Akar E, Mutlu H, Kilickap S. Tural D, et al. Among authors: kilickap s. Expert Rev Anticancer Ther. 2014 Sep;14(9):1089-96. doi: 10.1586/14737140.2014.929946. Epub 2014 Jun 26. Expert Rev Anticancer Ther. 2014. PMID: 24968823 Review.
Rituximab-related viral infections in lymphoma patients.
Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, Barista I. Aksoy S, et al. Among authors: kilickap s. Leuk Lymphoma. 2007 Jul;48(7):1307-12. doi: 10.1080/10428190701411441. Leuk Lymphoma. 2007. PMID: 17613758 Review.
Merkel cell carcinoma in Turkey: A multicentric study.
Yildiz F, Demirci U, Küçükarda A, Büyüksimsek M, Sakalar T, Topcu TO, Aslan F, Tufan G, Aydin O, Turna H, Babacan NA, Basoglu T, Kurt B, Yildiz B, Eren T, Demiray AG, Gumusay O, Arslan C, Özdemir N, Urun Y, Baykara M, Turan N, Uysal M, Bilici A, Kavgaci H, Çiçin İ, Kilickap S, Paydas S. Yildiz F, et al. Among authors: kilickap s. J Cancer Res Ther. 2021 Oct-Dec;17(6):1525-1529. doi: 10.4103/jcrt.JCRT_950_19. J Cancer Res Ther. 2021. PMID: 34916389 Free article.
182 results